also contributes to maintenance of minimal residual disease by promoting biologically relevant changes in tumor cells. These functional alterations of leukemic cells include, but are not limited to modulation
value <0.017 respectively). Conclusion: Tryptase may be useful for diagnosis, assessment of severity of disease (leukemic cells burden), monitoring minimal residual disease and prognosis of both AML and CML patients
cells and tissues by the high intensity conditioning or due to Graft Versus Host Disease (GVHD). As a major component of the curative potential of allo-HCT is derived from ... novel adoptive immunotherapy strategies…
risk of relapse. However, this procedure can ignite the graft vs. host disease in about 30% of patients post DLI. The lower rate of leukemia relapse in patients receiving alloHSCT ... marrow relapse emerged. In 4…
ASCT in these diseases is to achieve sustained donor engraftment to fight leukemic cells in malignant disease, improve hematopoietic function, provide immune competence or normalize enzyme deficiency. Peripheral blood
gastrointestinal bleeding. His transfusion requirement has also reduced. He remained in stable disease without further anti-leukemic therapy until February 2019 (16 months after withdrawal from the study) when…
Similarly, in chronic myeloid leukemia (CML), Wnt/β-catenin activation is observed in advanced disease, and inhibition of β-catenin in vivo potentiates the effect of tyrosine kinase inhibitors ... adult hematopoietic…
haemopoietic stem cell (HSC), leading to a hierarchical clonal stem cell disease, with the expanding leukemic stem cell (LSC) population sustaining the malignancy within the bone marrow (BM) niche ... population…
response to treatment can be difficult to predict. Sensitive monitoring of residual leukemic cell populations (minimal residual disease - MRD) is thus very important and holds great potential for improving treatment…
seems that those mothers who make one with their leukemic child go through all the processes of a chronic disease while being there for their child in spite
inflammation state and accordingly eliminating a potential trigger of clonal evolution and disease progression with myelofibrotic and leukemic transformation
disease remains context specific. Regardless of nomenclature, therapies that target the disease initiating cell, increase leukemic-cell immunogenicity, or activate immune cells may best achieve sustained positive…
basis of qualitative and empirical in nature. In a number of hematological diseases as well as in different pathological conditions like liver cirrhosis morphological alteration of red blood cell alteration ... blood…
concentration was also measured using ELISA. Results: Flow cytometric analysis of apoptotic leukemic cells indicated that the blockade of PD-1 and Tim-3 did not signifi cantly improve ... function of CD8+ T-cells in CLL…
frequency, typically targeting genes involved in signaling, epigenetic deregulation and leukemic transformation were identified, suggesting that MPNs are complex diseases, probably resulting from the combination of…
definition, minimal residual disease (MRD) is the persistence of leukemic cells after chemotherapy at numbers below the sensitivity detection level of routine morphology. MRD is the strongest prognostic parameter, guides
using two different models: a) sensitive and resistant human leukemic cell lines, b) tissue from patients with gestational trophoblastic disease (GTD). Up to now, we demonstrated that HA induced cell
name, even though they do not represent the same disease by nature. Moreover, when only a small number of leukemic cells are present, such as post-chemotherapy minimal residual leukemia
patients, continuous drug treatment is needed to prevent MRD cells from reinstating the disease. MRD cells serve as a reservoir of cells that can develop TKI resistance by acquiring mutations ... induced leukemia and…
attenuated CML-like myeloproliferative neoplasia (MPN), while leukemic cell-specific knockdown of the receptor for TGFβ1 (TGFβRI) exacerbated the disease. In contrast, AML was accelerated by the PTH-modified
Acute leukemias represent approximately 30% of malignant disease in patients under the age of 15 years. Leukemic infiltration of the central nervous system (CNS) and testis are common events especially ... children and…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.